Table 1. Baseline Demographic and Laboratory Characteristics a.
Variables | CBD/Δ9-THC (10:1) Group (n = 24) | Placebo Group (n = 22) | P-Value |
---|---|---|---|
Age, y | 55.7 ± 1.7 | 53.2 ± 1.3 | 0.26 |
Gender (males) | 6 (33.34) | 5 (27.8) | 0.99 |
Body mass index, kg/m 2 | 30.7 ± 0.8 | 31.2 ± 0.7 | 0.64 |
Current smoker | 3 (16.67) | 2 (11.2) | 0.99 |
Microvascular complications | 1 (5.6) | 1 (5.6) | 1 |
Hypertension | 0 (0) | 1 (5.6) | 0.99 |
Fasting glucose, mg/dL | 144.9 ± 17.9 | 139.2 ± 16.5 | 0.27 |
Cholesterol, mg/dL | 159.2 ± 10.2 | 145.8 ± 9.9 | 0.35 |
Triglyceride, mg/dL | 169.8 ± 21.4 | 134.2 ± 13.7 | 0.16 |
HDL-cholesterol, mg/dL | 41.06 ± 1.3 | 42.3 ± 1.6 | 0.57 |
LDL-cholesterol, mg/dL | 98.53 ± 8.2 | 86.9 ± 8.8 | 0.34 |
Creatinine, mg/dL | 0.96 ± 0.08 | 0.92 ± 0.06 | 0.2 |
Hb A1C , % | 7.94 ± 0.34 | 7.41 ± 0.16 | 0.18 |
Insulin baseline (mIU/L) | 26.27 ± 3.60 | 24.2 ± 3.70 | 0.08 |
HOMA2-IR | 3.68 ± 0.65 | 3.36 ± 0.66 | 0.10 |
HOMA2β | 91.2 ± 9.4 | 92.5 ± 9.3 | 0.80 |
a Values are expressed as No. (%) or mean ± SD.